IFNG and fungal infectious disease: Furthermore, Delsing et al. [101] showed that adjunctive therapy with IFN-γ and an antifungal drug partially restored immune function in patients with invasive Candida and/or Aspergillus infections indicating that further clinical studies are warranted to fully determine the potential clinical benefits of IFN-γ therapy during invasive fungal infections.